Researchers see benefits, little risk from renal denervation

10/29/2012 | MedPage Today

The use of renal nerve ablation to treat refractory high blood pressure appears to carry long-term benefits with little risk of adverse events, according to researchers from Australia's Baker Heart and Diabetes Institute in Melbourne who reported the findings at TCT 2012. Within a month, 69% of patients demonstrated a response to the treatment, and at the three-year mark, 94% of remaining study participants had responded.

View Full Article in:

MedPage Today

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Consumer Directed Health Plan (CDH) Product Offering Manager
Blue Cross Blue Shield MA
Quincy, MA
ISHN - Chief Compliance Officer
Mountain States Health Alliance
Johnson City, TN
Actuary
Meridian Health Plan
Detroit, MI
President/Chief Executive Officer
MedCost
Winston-Salem, NC
Director, Payer Marketing
Avalere Health
Washington, DC